Neogen (NEOG) senior VP receives 261,210 options and new share grants

Rhea-AI Filing Summary

Neogen Corporation reported that a senior vice president received new equity awards on 01/07/2026. The officer was granted 261,210 stock options with a conversion price of $7.38 per share, exercisable until 01/07/2036, covering 261,210 shares of common stock.

In addition, the officer acquired 50,813 shares of common stock linked to options and RSUs and another 50,813 shares tied to PSUs, both at a reference price of $7.38 per share. The options and RSUs vest in three equal annual installments, while the PSUs vest in full at the end of the three-year anniversary of the grant.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ranalli Tamara A.

(Last) (First) (Middle)

620 LESHER PLACE

(Street)

LANSING MI 48912

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NEOGEN CORP [ NEOG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Senior Vice President

3. Date of Earliest Transaction (Month/Day/Year)
01/07/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)
01/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/07/2026		A		50,813(1)	A	$7.38	50,813	D
Common Stock	01/07/2026		A		50,813(2)	A	$7.38	50,813	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Common Stock (Right to Buy)	$7.38	01/07/2026		A		261,210		(1)	01/07/2036	Common Stock	261,210	$0	261,210	D

Explanation of Responses:

1. Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants

2. PSUs vest in total at the end of the three year anniversary date of the grant

	Christopher Sefcheck (Attorney in Fact)	01/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider equity awards were reported for NEOG on this Form 4/A?

A Neogen senior vice president reported new equity awards on 01/07/2026, including 261,210 stock options and 101,626 common shares tied to RSUs and PSUs, all referenced at a share price of $7.38.

How many Neogen (NEOG) stock options were granted to the officer?

The officer received 261,210 stock options with a conversion price of $7.38 per share. These options are exercisable until 01/07/2036 and correspond to 261,210 shares of Neogen common stock.

What Neogen (NEOG) common shares were acquired through RSUs and PSUs?

The filing shows two acquisitions of 50,813 Neogen common shares each. One relates to options and RSUs, and the other to PSUs, both using a reference price of $7.38 per share for reporting purposes.

How do the Neogen (NEOG) options and RSUs from this filing vest?

The options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants. This creates three distinct vesting dates over a three-year period from the original 01/07/2026 grant date.

When do the Neogen (NEOG) PSUs from this grant vest?

The performance stock units (PSUs) vest in total at the end of the three-year anniversary date of the grant. All PSUs therefore vest together after three years from the 01/07/2026 grant date, rather than in annual installments.

Is the Neogen (NEOG) insider ownership in this Form 4/A direct or indirect?

The reported holdings are listed as direct ownership (D) for both the 101,626 common shares and the 261,210 derivative securities. No nature of indirect beneficial ownership is indicated for these transactions.